A Arthur Gottlieb

This inventor holds 15 USPTO granted patents. Top assignees: Imreg, Inc., Endeavor Corp., Imreg, Inc. (Delaware Corporation). Active years: 1984-1992.

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 1.1

ph-index = 7

Forward Citations = 116(Granted Patents)

Company Filing History:

Imreg, Inc. (Delaware Corporation)

patent

4. 1 out of 834,411

Other

patents

Years Active: 1984-1992

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5100663 - Tyr-Gly compositions useful in increasing immune response (1992-03-31),

2. 5093321 - Dialysates for treating aids and arc and for otherwise increasing immune (1992-03-03),

3. 5081108 - Method of showing progression of AIDS in an ARC patient by treating with (1992-01-14),

4. 5013546 - Methods for modulating antibody production in treating patients with (1991-05-07),

5. 4920097 - Immunosuppressor and method of extraction thereof from leukocytes (1990-04-24),

6. 4876193 - Determination of suppressor functional reserve (1989-10-24),

7. 4874608 - Therapeutic method for treating malignancies (1989-10-17),

8. 4778750 - Diagnostic methods for immune function (1988-10-18),

9. 4774176 - Sensitive tests for malignancies based on DNA detection (1988-09-27),

10. 4751216 - Methods for treating AIDS and ARC (1988-06-14),

11. 4710380 - Treatment of autoimmune disorders with immunoamplifiers (1987-12-01),

12. 4699898 - Tripeptides affecting immune response (1987-10-13),

13. 4616079 - Immunoamplifiers and processes for the extraction thereof (1986-10-07),

14. 4490472 - Sensitive tests for malignancies based on DNA detection (1984-12-25),

15. 4468379 - Leukocyte extracts for affecting the immune system (1984-08-28),

Title: A Arthur Gottlieb: Innovator in Immunology

Introduction

A Arthur Gottlieb is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of immunology, holding a total of 15 patents. His work focuses on developing compositions that enhance immune responses and provide therapeutic benefits for individuals suffering from immunodeficient conditions.

Latest Patents

Gottlieb's latest patents include innovative compositions aimed at increasing immune response. One of his notable inventions is a composition for delaying the progression from AIDS to ARC, which also alleviates symptoms associated with these diseases. This composition is based on a Tyr-Gly amino acid residue sequence and has shown promising clinical results in trials involving actual human patients. Typical dosage amounts for this composition are in the range of femtomoles per kilogram of body weight. Another significant patent involves purified human leukocyte dialysates designed for treating AIDS, ARC, and other immunodeficient conditions. These dialysates are purified through HPLC processes and are available in a form that is free of endotoxin and pyrogen. Notably, a dialysate designated Beta-1.11 consists essentially of endogenous Tyr-Gly, while Beta-1.12 consists of endogenous Tyr-Gly-Gly.

Career Highlights

Throughout his career, Gottlieb has worked with various companies, including Imreg, Inc. and Endeavor Corporation. His innovative work has contributed to advancements in treatments for serious health conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Gottlieb has collaborated with several professionals in his field, including Robert C Sizemore and Sudhir K Sinha. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

A Arthur Gottlieb's contributions to immunology through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to influence the development of treatments for immunodeficient conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]